NASDAQ:ALLO   Allogene Therapeutics, Inc.
There was a slight change in the markup. The goals remained the same. Medium-term 41-46$

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.